Biotech & Health Extension
Program

sponsored by 100 Plus Capital

A group of scientists, entrepreneurs, funders, and institutional allies who cooperate to advance biotechnology to reverse aging, extend human healthspans, and improve cognition. Meetings are private and may be off the record. Those that are recorded can be found in our seminar summaries page.
 
This group is sponsored by 100 Plus Capital. 100 Plus Capital invests in companies positively impacting human longevity. This can be directly targeted (for example, anti-aging companies) or broader reaching (clean food and water companies).
Seminar summaries
Apply to join
Support to join

UPCOMING PROGRAM

SEMINAR SUMMARIES

Recordings, written summaries and slides of previous keynotes

Reason, Fight Aging
Atherosclerosis: The As Yet Undefeated Monster
View keynote summary >

Emil Kendziorra
Aschwin De Wolf
Biostasis & Cryonics Q&A
View keynote summary >

Alexander Fedintsev, lifespan.io
Biohacking – A necessary component of a strategy for radical life extension
View keynote summary >

Daniel Belsky, Columbia University
Terrie Moffitt, Duke University.
The DunedinPoAm DNA Methylation Algorithm
View keynote summary >

Michael Snyder, Stanford University
Monitoring Personal Health and Ageotypes Using Big Data
View keynote summary >

Michael Levin, Tufts Center for Regenerative and Developmental Biology
Bioelectric Networks: Taming the Collective Intelligence of Cells for Regenerative Medicine
View keynote summary >

Daniel Ives, Shift Bioscience
Drug Target Discovery for Cellular Rejuvenation by ‘Driver’ Clocks
View keynote summary >

Nir Barzilai, Albert Einstein School of Medicine
TAME Q&A: Lessons for Progress on Aging
View keynote summary >

Keith Murphy, Organovo, Viscient Biosciences
David Gobel, Methuselah Foundationt
Patient Trials in a Dish” Paths Forward
View keynote summary >

Morgan Levine, Yale
Jamie Justice, Wake Forest
Biomarker Standardization
View keynote summary >

Steve Horvath, UCLA
EpigeneticClocks: What’s New & What’s Missing?
View keynote summary >

Vadim Gladyshev, Harvard
Gordan Lauc, GlycanAge
Biomarker & Aging Clock Development
View keynote summary >

Alex Zhavoronkov, Deep Longevity & Insilico Medicine
Longevity as a Service: AI & Aging Clocks
View keynote summary >

Greg Fahy, Intervene Immune
Thymus Rejuvenation Progress Update
View keynote summary >

Christopher Leptak, CDER Biomarker Qualification Program, FDA
Biomarkers and Drug Development: Regulatory Perspective
View keynote summary >

James Peyer, Cambrian Biopharma
How to Fund and Build Geroprotectors
View keynote summary>

Ronald Kohanski, National Institute on Aging
Institutional perspective: What work could dramatically advance progress on aging from an NIA perspective?
View keynote summary >

James Kirkland, Mayo Clinic
Clinical Trials & Senolytics Q&A
View keynote summary >

Jean Hebert, Albert Einstein School of Medicine
Brain Cell Replacement as the Cornerstone to Beating Aging
View keynote summary >

Brian Kennedy, Buck Institute
Joris Deelen, Max Planck Institute for Aeging
Lynne Cox, Oxford University
Underincentivized Basic Research In Health Extension
View keynote summary >

     

Brian Kennedy, Buck Institute
Joris Deelen, Max Planck Institute for Aeging
Lynne Cox, Oxford University
Underincentivized Basic Research In Health Extension
View keynote summary >

Irina Conboy, UC Berkeley
Tissue Rejuvenation via Plasma Dilution
View keynote summary >

Sonia Arrison, 100 Plus Capital
Karl Pfleger, Agingbiotech.info
Mike West, AgeX
Industry Blindspots for Dramatically Advancing Progress in Health Extension
View keynote summary >

Sonia Arrison, 100 Plus Capital
Karl Pfleger, Agingbiotech.info
Mike West, AgeX
Industry Blindspots for Dramatically Advancing Progress in Health Extension
View keynote summary >

Allison Duettmann, Foresight Institute
Sonia Arrison, 100 Plus Capital
Define 2021 Goals
View keynote summary >

Allison Duettmann, Foresight Institute
Sonia Arrison, 100 Plus Capital
Define 2021 Goals
View keynote summary >